Pharma doesn't need more news.
It needs sharper signal.

Hello Pharma is a B2B intelligence platform for the pharmaceutical manufacturing industry. It brings together strategic intelligence, technical expertise, and AI-powered capabilities to help industry leaders understand what is changing, where opportunities lie, and what to do next.

Through authoritative editorial, market intelligence, industry conversations, and intelligent digital platforms, Hello Pharma connects knowledge with action. It helps pharma businesses make sharper decisions, build strategic relationships, and navigate an increasingly complex industry.

Visitors
Member Community52K+
Countries Mapped15+
Pharma Projects Listed1000+
Hello Pharma Explore

Long-form. On the record.

Conversations with the leaders, founders, and regulators shaping pharma's next decade.

All Episodes →

Official Media Partner for.

Live Calendar

What's coming next.

248 events tracked. Trade shows, conferences, awards, summits — all curated for pharma manufacturing leaders.

Add Event Details

Why Hello Pharma

Built for pharma's operating reality.

🛡️

Editorial Independence

Sponsored content is clearly labeled. Editorial coverage is never paid placement. The line is bright and stays bright.

⚡

Leader Voice

Long-form reporting from inside the plants. Conversations with quality heads, plant managers, and CDMOs — not just CEOs.

📊

Data-Backed

Every claim sourced. Every chart re-buildable. Editorial paired with PharmaFormula's engineering reference engine.

🌐

Global Reach

India, ASEAN, EU, USFDA-aligned coverage. 12,000+ subscribers across 15 countries. One pharma trade desk.

Leader Talks

Trusted by pharma's leaders.

"

Pharma 4.0 is not about adopting technology. It's about earning the right to make faster decisions with the same data integrity standards.

Sekhar Surabhi On Pharma 4.0
★★★★★
"

Net-zero in pharma cannot be a marketing line. The molecule, the mandate, and the material reality have to balance — or none of it lasts.

Shankari Swaminathan On Sustainability
★★★★★
"

We're building plants faster than we're building the operating discipline to run them. The bill comes due in year three.

Abhay Inamdar On Capital Projects
★★★★★